AAAMD is a partner in INSIGHT – Health Data Research Hub for Eye Health. INSIGHT is one of the seven pioneering data research centres to enable cutting-edge research and innovation to benefit UK patients.

There is an increasing demand for ‘big data’ to enable innovation...

The initial results from an artificial intelligence project show a number of existing drugs have the potential to reduce sight loss from age-related macular degeneration, the leading cause of sight loss.

Action Against AMD, a research collaboration formed by four UK sig...

Rob Bryan, Development Chair at Action Against AMD, said: “Action Against AMD was primarily founded with the aim of finding ways of preventing early stage age-related macular degeneration (AMD) developing into late-stage AMD and causing significant loss of vision. The...

BenevolentAI and Action Against AMD, a group of UK sight loss charities, have today announced their partnership to use BenevolentAI’s technology to find treatments and a potential cure for the leading cause of blindness in the UK – ‘age-related macular degeneration’ (A...

Four leading sight loss charities have announced a unique partnership to find a treatment for one of the world’s leading causes of blindness. 

Blind Veterans UK, Fight for Sight, the Macular Society and Scottish War Blinded are jointly launching a collaboration to trans...

Three leading sight loss charities, Blind Veterans UK, Fight for Sight and the Macular Society, have joined forces in the global fight against age-related macular degeneration (AMD). The main objective of the collaboration, which is called Action Against Age-Related Ma...

The Macular Society has launched a landmark report exposing the lack of funding for biomedical research into age-related macular degeneration (AMD), the leading cause of sight loss in the UK.

The report, which has been funded by the Clothworkers’ Foundation and has been...

Despite on-going research in the UK and worldwide, there are still many questions about the prevention, diagnosis and treatment of sight loss and eye conditions that remain unanswered. Funding for research is limited, so it is important for research funders to understa...